ZEB1 and breast cancer: In oncogenic conditions, a large array of microRNAs have also been reported to inhibit Zeb1 expression leading therefore to EMT blockage: miR-33 in adenocarcinoma [197], miR-126 in osteosarcoma [198], miR-128 in esophageal squamous cell cancer [199], miR-150 [200] and miR-200 in ovarian [201] and breast cancer [202], miR-205 [203] and miR-429 [204] and miR-484 [205] in cervical carcinoma, miR-652 in pancreatic cancer [206], miR-875 in prostate cancer [207], miR-23 in bladder cancer [208] and miR-205 in glioblastoma [209].